e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection
Albanna Amr S., Bachmann Kenneth, White Donald, Valiquette Chantal, Menzies Dick
Source:
Eur Respir J 2013; 42: 547-550
Journal Issue:
August
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Albanna Amr S., Bachmann Kenneth, White Donald, Valiquette Chantal, Menzies Dick. Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection. Eur Respir J 2013; 42: 547-550
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Tuberculosis in renal transplant recipients on isoniazid prophylaxis
Diagnosis of Latent TB Infection: the role of IGRAs
Related content which might interest you:
Urinary neopterin levels discriminate active from latent mycobacterium tuberculosis infection
Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis
Year: 2011
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Serum Procalcitonin for diagnosing and monitoring response in pleural infection
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 1-3
Year: 2006
The identification of tuberculosis biomarkers in human urine samples
Source: Eur Respir J 2014; 43: 1719-1729
Year: 2014
Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
Capacities of blood serum lipoarabinomannan in the diagnosis of tuberculosis at a late stage of HIV infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease
Source: International Congress 2017 – Update on TB: latest news
Year: 2017
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 569-571
Year: 2015
The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
Source: Eur Respir J 2015; 45: 571-574
Year: 2015
Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002
Evaluation of new biomarkers for laboratory diagnosis of tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
Is neopterin concentration predictive in latent tuberculosis infection in health workers?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008
Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011
Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 455s
Year: 2005
The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 1283
Year: 2006
Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum
Source: Eur Respir J 2014; 44: 254-257
Year: 2014
Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept